Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Paul Singer Reiterates 6.4% Stake in Emulex, Reveals New Agreement in Play

Paul Singer and his mega-hedge fund, Elliott Associates, has just reiterated its 6.4% stake in Emulex Corporation (NYSE:ELX), while disclosing a letter agreement with the company. Here are the contents of the agreement:

Pursuant to the terms of the Letter Agreement, the Issuer agreed that prior to filing its proxy materials for the next meeting of stockholders at which members of the Issuer’s Board of Directors (the “Board”) will be elected (the “Next Stockholders Meeting”), the Board (and the Nominating/Corporate Governance Committee and/or an authorized subcommittee thereof) will, among other things, take such actions as necessary to (i) decrease (effective as of immediately prior to the Next Stockholders Meeting and continuing until the Expiration Date, as defined below), the size of the Board to no more than 11, (ii) nominate no more than eight individuals who are currently members of the Board (the “Existing Director Nominees”), including Eugene J. Frantz and Gregory S. Clark (the “New Members”), for election to the Board at the Next Stockholders Meeting, and (iii) nominate for election to the Board at the Next Stockholders Meeting three individuals from the group of candidates previously identified by the Board and the Reporting Persons(the “Designated Nominees” and, together with the Existing Director Nominees, the “Issuer Nominees”).  
Disclosure: none

Recommended Reading:

Eric Bannasch’s Cadian Capital Lowers Stake in LogMeIn

Glenn Greenberg’s Brave Warrior Capital Cuts Stake in Higher One Holdings

Robert Pitts, Steadfast Capital Report New Position in

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!